Clinical and molecular evidence of abnormal processing and trafficking of the vasopressin preprohormone in a large kindred with familial neurohypophyseal diabetes insipidus due to a signal peptide mutation

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 8, 1999, Pages 2933-2941

  Siggaard, Charlotte ^a   Rittig, Søren ^a   Corydon, Thomas J ^b   Andreasen, Per Hove ^a   Jensen, Thomas G ^b   Andresen, Brage S ^a   Robertson, Gary L ^c   Gregersen, Niels ^a   Bolund, Lars ^b   Pedersen, Erling B ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE PRECURSOR; PREPROVASOPRESSIN; SIGNAL PEPTIDE; UNCLASSIFIED DRUG; VASOPRESSIN;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES INSIPIDUS; ENDOPLASMIC RETICULUM; FAMILIAL NEUROHYPOPHYSEAL DIABETES INSIPIDUS; FEMALE; GENE MUTATION; HORMONE URINE LEVEL; HUMAN; MALE; POLYURIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; URINE VOLUME; VASOPRESSIN BLOOD LEVEL; VASOPRESSIN RELEASE;

EID: 0033334318     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.8.2933     Document Type: Article

References (51)

1. Vasopressin function in familial cranial diabetes insipidus
2. Radioimmunoassay of vasopressin in familial cental diabetes insipidus
3. Familial central diabetes insipidus: Vasopressin and nicotine stimulated neurophysin deficiency with subnormal oxytocin and estrogen stimulated neurophysin
4. Familial cranial diabetes insipidus: A report of five families. Genetic, diagnostic and therapeutic aspects
5. Plasma vasopressin in hereditary cranial diabetes insipidus
6. Familial neurohypophyseal diabetes insipidus associated with a signal peptide mutation
7. On hereditary diabetes insipidus with special regard to a sex-linked form
8. Hereditary diabetes insipidus: A case report with autopsy findings
9. Hereditary and ideopathic types of diabetes insipidus
10. Hereditary diabetes insipidus: An immunohistochemical study of the hypothalamus and pituitary gland
11. A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus
12. A missense mutation in the vasopressin-neurophysin precursor gene cosegregates with human autosomal dominant neurohypophyseal diabetes insipidus
13. Possible involvement of inefficient cleavage of preprovasopressin by signal peptidase as a cause for familial central diabetes insipidus
14. Glu-47, which forms a salt bridge between neurophysin-II and arginine vasopressin, is deleted in patients with familial central diabetes insipidus
15. 24→Leu) is associated with onset and transmission of autosomal dominant neurohypophyseal diabetes insipidus
16. Two novel mutations in the coding region for neurophysin-II associated with familial central diabetes insipidus
17. Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidus
18. A novel mutation in the coding region for neurophysin-II is associated with autosomal dominant neurohypophyseal diabetes insipidus
19. A new type of familial central diabetes insipidus caused by a single base substitution in the neurophysin II coding region of the vasopressin gene
20. Recurrent mutations in the vasopressin-neurophysin II gene cause autosomal dominant neurohy-pophyseal diabetes insipidus
21. A novel point mutation in the translation initiation codon of the pre-pro-vasopressin-neurophysin II gene: Cosegregation with morphological abnormalities and clinical symptoms in autosomal dominant neurohypophyseal diabetes insipidus
22. Heterogeneity in clinical manifestation of autosomal dominant neurohypophyseal diabetes insipidus caused by a mutation encoding Ala-1->Va1 in the signal peptide of the arginine vasopressin/neurophysin II/copeptin precursor
23. 23→Va1 in neurophysin II
24. Identification of a novel nonsense mutation and a missense substitution in the vasopressin-neurophysin II gene in two Spanish kindreds with familial neurohypophyseal diabetes insipidus
25. Identification of mutations of the arginine vasopressin-neurophysin II gene in two kindreds with familial central diabetes insipidus
26. Substitution of Tyr-2 of the anti-diuretic hormone is associated with familial neurohypophyseal diabetes insipidus [Abstract]
27. Genetic basis of familial neurohypophyseal diabetes insipidus
28. Familial neurohypophyseal diabetes insipidus: A novel mutation presenting with enuresis [Abstract]
29. A novel mutation in a coding region of the arginine vasopressin-neurophysin II (AVP-NPII) gene in a family with autosomal dominant neurohypophyseal diabetes insipidus [Abstract]
30. Two novel mutations of the vasopressin gene associated with familial diabetes insipidus and identification of an asymptomatic carrier infant
31. The human vasopressin gene is linked to the oxytocin gene and is selectively expressed in a cultured lung cancer cell line
32. Molecular basis of autosomal dominant neurohypophyseal diabetes insipidus. Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum
33. Heterologous expression of human vasopressin-neurophysin precursors in a pituitary cell line: Defective transport of a mutant protein from patients with familial diabetes insipidus
34. A comparison of plasma vasopressin measurements with a standard indirect test in the differential diagnosis of polyuria
35. Effect of indapramide on renal plasma flow, glomerular filtration rate, and arginine vasopressin in plasma in essential hypertension
36. Expression of the vasopressin and oxytocin genes in human hypothalami
37. Improved site-directed mutagenesis method using PCR
38. A new technique for the assay of infectivity of human adenovirus 5 DNA
39. Expression of wild-type and mutant medium-chain acyl-CoA dehydrogenase (MCAD) cDNA in eucaryotic cells
40. Rapid characterization of desease-causing mutations in the low density lipoprotein receptor (LDL-R) gene by overexpression in COS cells
41. Antibodies: A laboratory manual
42. A C-terminal signal prevents secretion of luminal ER proteins
43. Effects of aging on vasopressin secretion, water excretion, and thirst in man
44. The regulation of vasopressin function in health and disease
45. Heterologous biosynthesis and processing of preprovasopressin in Neuro2A neuroblastoma cells
46. Functional role of hormone-neurophysin association in hormone biosynthesis
47. Pathogenesis and pathophysiology of familial neurohypophyseal diabetes insipidus
48. A vasopressin-neurophysin gene (VPNP) mutation linked to familialneurhypophyseal diabetes insipidus (FNDI) impairs the maturation and vasopressin (VP) production of stably transfected neuroblastoma 2A (N2A) cells [Abstract]
49. Maturation of Escherichia coli maltose-binding protein by signal peptidase I in vivo
50. Functional limits of conformation, hydrophobicity, and steric constraints in prokaryotic signal peptide cleavage regions
51. The conformation and functional domains of neurophysins